VIOME LIFE SCIENCES
Bellevue, WA, United States · Biotechnology, Health Care, Other · 200 employees
Viome Life Sciences was founded in 2016 with a mission to make illness optional by predicting and preventing chronic diseases, cancers, and aging through a deeper understanding of an individual's biology at a molecular level. Viome's Consumer Services (VIOME) provides the industry's only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA), with technolog
Funding history
- Venture - Series Unknown — $25.4M — Aug 2024
- Series C — $67.0M — Oct 2022
- Venture - Series Unknown — $67.0M — Oct 2022
- Seed — $3.0M — Feb 2021
- Venture - Series Unknown — $36.5M — Nov 2019
Recent signals
- Aug 28, 2024: Raised $25.4M in Venture - Series Unknown
- Oct 18, 2022: Raised $67.0M in Series C
- Oct 11, 2022: Raised $67.0M in Venture - Series Unknown
- Feb 11, 2021: Raised $3.0M in Seed
- Nov 27, 2019: Raised $36.5M in Venture - Series Unknown
- Jul 03, 2018: Raised $5.5M in Venture - Series Unknown
- Jul 28, 2017: Raised $15.0M in Venture - Series Unknown
See plans & pricing → Track VIOME LIFE SCIENCES’s funding, hiring, and signals — with verified contacts — on Fundz.